Clinical Scorecard: Advancing early detection during Head and Neck Cancer Awareness Month

At a Glance

Key Highlights

• Accounts for nearly 5% of all cancers in the U.S.
• Risk factors include tobacco, alcohol, and high-risk HPV
• Warning signs include persistent neck mass and nonhealing mouth sore
• UCI Health offers multidisciplinary care and advanced treatments
• Access to clinical trials and immunotherapy available

Guideline-Based Recommendations

Diagnosis

• Identify warning signs such as persistent neck mass and hoarseness
• Consider HPV testing in relevant cases

Management

• Utilize advanced surgical treatment options
• Implement transoral robotic surgery for HPV-related cancers

Monitoring & Follow-up

• Regular follow-ups for patients post-treatment
• Monitor for recurrence and treatment side effects

Risks

• Increased risk associated with tobacco and alcohol use
• Potential complications from advanced surgical procedures

Patient & Prescribing Data

Patients diagnosed with head and neck cancers

Focus on multidisciplinary care and access to innovative therapies

Clinical Best Practices

• Encourage early detection through awareness of warning signs
• Provide comprehensive care involving multiple specialties
• Facilitate access to clinical trials for eligible patients

Related Resources & Content

• UCI Health Head and Neck Oncologic Program